Yanai Shlomo
SEC insider (Form 3/4/5 filer). CIK 0001562645. Director at Amneal Pharmaceuticals, Inc. (AMRX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in STAMFORD, CT.
Companies Yanai Shlomo has filed insider reports for
- Amneal Pharmaceuticals, Inc. (AMRX): Director
- Philip Morris International Inc. (PM): Director
Yanai Shlomo
CIK: 0001562645
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 7, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect34.8K shares- - May 6, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
19.8K shares- - May 6, 2026PM
Philip Morris International Inc.
AwardDirect1.1K shares at avg. $169.93$190K - May 7, 2025PM
Philip Morris International Inc.
AwardDirect1K shares at avg. $174.82$175K - May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
34.8K shares- - May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect40.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 7, 2026 |  AMRX Amneal Pharmaceuticals, Inc. | Exercise | 34,819 | - | $0 | Direct |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award Restricted Stock Units | 19,824 | - | - | Direct |
| May 6, 2026 |  PM Philip Morris International Inc. | Award | 1,119 | $169.93 | $190,152 | Direct |
| May 7, 2025 | PM Philip Morris International Inc. | Award | 1,002 | $174.82 | $175,170 | Direct |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award Restricted Stock Units | 34,819 | - | - | Direct |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 40,258 | - | - | Direct |
1-6 of 6 transactions